The effects of e-cigarette visual appearance on craving and withdrawal symptoms in abstinent smokers. 2016

Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
School of Psychology, University of East London.

Electronic cigarette (e-cigarette) use is becoming increasing popular among smokers, and there is a plethora of devices available. Nicotine delivery is clearly important for reducing tobacco craving and withdrawal symptoms, but other sensorimotor aspects of e-cigarettes (such as visual appearance) may contribute to this effect. This study explored whether it is important for an e-cigarette to visually resemble a tobacco cigarette in order to reduce craving and withdrawal symptoms. Sixty-three cigarette smokers (40% female, aged 18-65 years) who were not current e-cigarette users were randomly allocated to take ten 3-s puffs from either a white or a red first-generation e-cigarette following overnight abstinence. Current craving (urge to smoke) and nicotine withdrawal symptoms (using the Mood and Physical Symptoms Scale [MPSS]) were measured before and 10 min after use. Linear regression revealed higher craving and withdrawal symptoms in the red condition versus the white condition, but only among those who were e-cigarette naive (craving: B = .76, p = .009; withdrawal symptoms: B = 2.18, p = .009), not among those with e-cigarette experience (craving: B = -.08, p = .89; withdrawal symptoms: B = .24, p = .81), and these effects differed between groups (p = .04 and 0.01 for craving and withdrawal symptoms, respectively). In conclusion, cigarette-like appearance was associated with lower craving and withdrawal symptoms, but only for those with no prior e-cigarette experience. This effect, putatively mediated via classical conditioning or expectancies, may aid understanding of smokers' initial preferences for "cigalike" e-cigarette devices.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D016540 Smoking Cessation Discontinuing the habit of SMOKING. Giving Up Smoking,Quitting Smoking,Stopping Smoking,Cessation, Smoking,Smoking Cessations,Smoking, Giving Up,Smoking, Quitting,Smoking, Stopping,Smokings, Giving Up,Up Smoking, Giving
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
May 2002, Psychopharmacology,
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
May 2007, Psychopharmacology,
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
July 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco,
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
March 2015, Behavior therapy,
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
January 1986, Psychopharmacology,
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
February 2013, Psychopharmacology,
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
March 2014, Addictive behaviors,
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
November 2007, Journal of psychopharmacology (Oxford, England),
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
May 1994, Clinical pharmacology and therapeutics,
Lynne Dawkins, and Marcus Munafò, and Gina Christoforou, and Naomi Olumegbon, and Kirstie Soar
July 2004, Progress in neuro-psychopharmacology & biological psychiatry,
Copied contents to your clipboard!